KemPharm's Series D Round

KemPharm raised a round of funding on March 04, 2015. Investors include Deerfield Management.

KemPharm is a biopharmaceutical company focused on the discovery and development of new chemical entities (NCEs) to treat serious medical conditions through its proprietary and broadly applicable Liga…

Articles about KemPharm's Series D Round: